Wall Street Zen Downgrades Bayer Aktiengesellschaft (OTCMKTS:BAYRY) to Hold

Wall Street Zen downgraded shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Free Report) from a buy rating to a hold rating in a report issued on Friday.

Other equities research analysts have also recently issued reports about the stock. The Goldman Sachs Group raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Hsbc Global Res upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 11th. Finally, Kepler Capital Markets raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Wednesday, June 11th. Two analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy".

Bayer Aktiengesellschaft Stock Down 1.7%

OTCMKTS BAYRY traded down $0.14 on Friday, hitting $7.98. 268,546 shares of the stock were exchanged, compared to its average volume of 433,139. Bayer Aktiengesellschaft has a fifty-two week low of $4.79 and a fifty-two week high of $8.58. The company has a 50-day moving average price of $7.33 and a 200-day moving average price of $6.34. The company has a quick ratio of 0.79, a current ratio of 1.25 and a debt-to-equity ratio of 1.07. The company has a market cap of $31.36 billion, a PE ratio of -8.67 and a beta of 0.86.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported $0.65 EPS for the quarter, beating analysts' consensus estimates of $0.63 by $0.02. The business had revenue of $15.27 billion for the quarter, compared to the consensus estimate of $13.39 billion. Bayer Aktiengesellschaft had a positive return on equity of 13.94% and a negative net margin of 7.26%. Sell-side analysts anticipate that Bayer Aktiengesellschaft will post 1.31 EPS for the current fiscal year.

Bayer Aktiengesellschaft Increases Dividend

The business also recently declared a dividend, which was paid on Monday, May 12th. Stockholders of record on Wednesday, April 30th were given a dividend of $0.0224 per share. This represents a dividend yield of 0.38%. This is an increase from Bayer Aktiengesellschaft's previous dividend of $0.02. The ex-dividend date was Tuesday, April 29th. Bayer Aktiengesellschaft's dividend payout ratio (DPR) is presently -2.17%.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.